Prevacid and Hypertrophy - a phase IV clinical study of FDA data

Summary:

Hypertrophy is reported as a side effect among people who take Prevacid (lansoprazole), especially for people who are female, 60+ old, also take Aredia, and have Metastases to bone.

The phase IV clinical study analyzes which people have Hypertrophy when taking Prevacid. It is created by eHealthMe based on reports of 128,835 people who have side effects when taking Prevacid from the FDA, and is updated regularly.

What is Prevacid?

Prevacid has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 130,714 Prevacid users. Check the latest studies of Prevacid.

What is Hypertrophy?

Hypertrophy (increase in the volume of an organ or tissue due to the enlargement of its component cells) is found to be associated with 243 drugs and 290 conditions by eHealthMe. Check the latest studies of Hypertrophy.

On Jul, 13, 2026

128,835 people reported to have side effects when taking Prevacid.
Among them, 18 people (0.01%) have Hypertrophy.

Among these 18 people:

What is the gender of people who have Hypertrophy when taking Prevacid? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Hypertrophy when taking Prevacid? *

What are other drugs people take besides Prevacid? *

What are other side effects people have besides Hypertrophy? *

Chest Pain: 9 people, 50.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 50.00%
Pain: 9 people, 50.00%
Stress And Anxiety: 9 people, 50.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 7 people, 38.89%
Intervertebral Disc Protrusion (spinal disc protrusion): 7 people, 38.89%
Osteonecrosis Of Jaw (death of bone of jaw): 7 people, 38.89%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 38.89%
Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 38.89%
Atelectasis (partial or complete collapse of the lung): 7 people, 38.89%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 4 people, 22.22%
Pain: 2 people, 11.11%
Osteoporosis (bones weak and more likely to break): 2 people, 11.11%
Breast Cancer Metastatic: 2 people, 11.11%
Bone Loss: 2 people, 11.11%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.56%
Muscle Disorder (muscle disease): 1 person, 5.56%
Inflammation: 1 person, 5.56%
Indigestion: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Prevacid and have Hypertrophy?

- Check whether Hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prevacid:

Prevacid (130,714 reports)

Hypertrophy treatments and more:

Hypertrophy (835 reports)

Browse all side effects of Prevacid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertrophy:

Hypertrophy (243 drugs)

Browse all the conditions that are associated with Hypertrophy:

Hypertrophy (290 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole (the active ingredients of Prevacid) and Prevacid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.